Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

As life science professionals, we not only continuously handle hard science and research, but we also have to learn how to market our products and interact with a large online audience. However, ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

Aiolos Bio has emerged as a significant player in the biopharmaceutical industry, with a focus on developing treatments for respiratory and inflammatory diseases. The company’s launch in 2023, backed ...

Unlike other industries, biotech startups often require substantial initial capital to support extensive research and development (R&D), clinical trials, and regulatory approvals before generating any ...

When David Bennet received a new heart in January 2022, there was something very unusual about the organ being transplanted into his body – instead of coming from a human donor, it was actually a ...

Discovered in the late 1990s, Small interfering RNA (siRNA) is a class of double-stranded RNA molecules, involved in the RNA interference (RNAi) pathway, where it mediates the silencing of specific ...

Research in the field of inflammatory diseases has become one of the hottest areas of drug development, spurred on by an interest in novel therapies that have the potential to be more precise and more ...